{"id":40595,"date":"2025-05-14T10:58:46","date_gmt":"2025-05-14T05:28:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=40595"},"modified":"2025-05-14T10:59:08","modified_gmt":"2025-05-14T05:29:08","slug":"accretion-pharmaceuticals-ipo-gmp","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/","title":{"rendered":"Accretion Pharmaceuticals IPO GMP: Day 1 IPO Live Updates"},"content":{"rendered":"<p><strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP <\/strong>is \u20b98 as of 14th May 2025. The IPO opens for bidding today, 14th May 2025, and will close on 16th May 2025. It is a bookbuilding IPO consisting of a fresh issue of 29.46 lakh shares worth \u20b929.75 crores. The issue will be listed on NSE and SME on its tentative listing date, 21st May 2025. The price band for the Accretion Pharmaceuticals IPO is set between \u20b996 and \u20b9101 per share. Retail investors can bid for a minimum lot of 1,200 shares worth \u20b91,21,200.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Accretion_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\" title=\"Accretion Pharmaceuticals IPO GMP Grey Market Premium\">Accretion Pharmaceuticals IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Accretion_Pharmaceuticals_IPO_Details\" title=\"Accretion Pharmaceuticals IPO Details\">Accretion Pharmaceuticals IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Objectives_of_Accretion_Pharmaceuticals_IPO\" title=\"Objectives of Accretion Pharmaceuticals IPO\">Objectives of Accretion Pharmaceuticals IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Accretion_Pharmaceuticals_IPO_Registrar\" title=\"Accretion Pharmaceuticals IPO Registrar&nbsp;\">Accretion Pharmaceuticals IPO Registrar&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Accretion_Pharmaceuticals_IPO_Review\" title=\"Accretion Pharmaceuticals IPO Review\">Accretion Pharmaceuticals IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Accretion_Pharmaceuticals_IPO_Technical_Analysis\" title=\"Accretion Pharmaceuticals IPO Technical Analysis\">Accretion Pharmaceuticals IPO Technical Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#FAQs_on_Accretion_Pharmaceuticals_IPO\" title=\"FAQs on Accretion Pharmaceuticals IPO\">FAQs on Accretion Pharmaceuticals IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#What_is_Accretion_Pharmaceuticals_IPO_GMP\" title=\"What is Accretion Pharmaceuticals IPO GMP?\">What is Accretion Pharmaceuticals IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#What_is_the_issue_price_of_Accretion_Pharmaceuticals_IPO\" title=\"What is the issue price of Accretion Pharmaceuticals IPO?\">What is the issue price of Accretion Pharmaceuticals IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Who_is_the_registrar_of_Accretion_Pharmaceuticals_IPO\" title=\"Who is the registrar of Accretion Pharmaceuticals IPO?\">Who is the registrar of Accretion Pharmaceuticals IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo-gmp\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 14th May 2025, <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP <\/strong>stands at \u20b90 per share. Thus, the estimated listing price would be \u20b9109 (101+8). This indicates that the estimated listing gain in this IPO could be 7.92%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table below to learn about recent Accretion Pharmaceuticals IPO GMP updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>14-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b98<\/td><td>\u20b9109<\/td><td>7.92%<\/td><\/tr><tr><td><strong>13-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b98<\/td><td>\u20b9109<\/td><td>7.92%<\/td><\/tr><tr><td><strong>12-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>11-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>10-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>09-04-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>08-04-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>07-04-2025<\/strong><\/td><td>\u20b9101<\/td><td>\u20b90<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Details\"><\/span><strong>Accretion Pharmaceuticals IPO<\/strong><strong> Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>14th May 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>16th May 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>19th May 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>20th May 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>29,46,000 shares (worth \u20b929.75 crore)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,200 shares<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b996 to \u20b9101 per share<\/td><\/tr><tr><td><strong>Market Makers Portion<\/strong><\/td><td>1,47,600 shares<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>21st May 2025<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Accretion Pharmaceuticals IPO<\/strong>: <a href=\"https:\/\/accretionpharma.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Accretion Pharmaceuticals Limited<\/a> has declared a price band of \u20b996 to \u20b9101 per share. With this IPO, the company allows retail investors to bid for at least one lot of 1,200 shares worth \u20b91,21,200. The face value of Accretion Pharmaceuticals Ltd.&#8217;s share is \u20b910 per share. The shares of Accretion Pharmaceuticals Limited, one of the pharma companies in India, will be listed on NSE &amp; SME on its tentative listing day, 21st May 2025. Scroll down to check GMP updates and Accretion Pharmaceuticals IPO reviews.\u00a0<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Objectives_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Objectives of <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals Limited proposed to utilise the proceeds from the book-building issue in the following objectives.&nbsp;<\/p><ul class=\"wp-block-list\"><li>To meet capital expenditure on machinery and equipment.<\/li>\n\n<li>To meet general corporate purposes.\u00a0<\/li>\n\n<li>To meet the repayment of certain borrowings availed by the company.<\/li>\n\n<li>To meet the working capital requirements of the company.\u00a0<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Registrar\"><\/span><strong>Accretion Pharmaceuticals IPO<\/strong><strong> Registrar&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals IPO is open today, on 14th May 2025, to raise \u20b929.75 crore.&nbsp; Kfin Technologies Limited is the registrar of <strong>Accretion Pharmaceuticals IPO<\/strong><strong>,<\/strong> awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Accretion Pharmaceuticals IPO allotment and refund, you can contact Kfin Techologies Limited at <a href=\"mailto:reachus@kfintech.com\">reachus@kfintech.com<\/a> or 04067162222, 04079611000.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Review\"><\/span><strong>Accretion Pharmaceuticals IPO<\/strong><strong> Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-1024x536.jpg\" alt=\"\" class=\"wp-image-40597\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The Accretion Pharmaceuticals IPO has gained neutral ratings from industry experts, brokers, and institutional investors. During FY23- 24, Accretion Pharmaceuticals Limited&#8217;s revenue rose 14.93% from \u20b929.53 crores in March 2023 to \u20b933.94 crores in March 2024. Moreover, the company&#8217;s PAT increased by 3,780.00% from \u20b90.10 crores to \u20b93.88 crores.&nbsp; However, industry experts suggest applying for this IPO with a long-term perspective. However, industry experts suggest that investors may park funds in this IPO for the long term.<\/p><p>Most analysts recommend avoiding this IPO to safeguard your investment portfolio in the stock market. However, we\u2019re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Accretion Pharmaceuticals IPO<\/strong> or not.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Technical_Analysis\"><\/span><strong>Accretion Pharmaceuticals IPO<\/strong><strong> Technical Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>21.29<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>4.74<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>72.47%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-equity\"><strong>ROE<\/strong><\/a><strong> (Return on Equity)<\/strong><\/td><td>72.47%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>36.73%<\/td><\/tr><tr><td><strong>PAT Margin (Profit After Tax)<\/strong><\/td><td>11.51<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9112.27 crore<\/td><\/tr><\/tbody><\/table><\/figure><p>The PE ratio of Accretion Pharmaceuticals Limited shares is 21.29, and its Earnings Per Share (EPS) stands at 4.74. The Accretion Pharmaceuticals IPO can potentially deliver gains on its tentative listing date, 21st May 2025.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>21.29<\/td><td>16.08<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>4.74<\/td><td>6.28<\/td><\/tr><\/tbody><\/table><\/figure><p><em>For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Accretion_Pharmaceuticals_IPO\"><\/span><strong>FAQs on <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Accretion_Pharmaceuticals_IPO_GMP\"><\/span><strong>What is <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Currently, on 14th May 2025, <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP<\/strong> (Grey Market Premium) stands at \u20b98 (7.92 % up). This indicates that the estimated listing price could be \u20b9109 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong>What is the issue price of <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong>?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. The <strong>Accretion Pharmaceuticals IPO<\/strong> price band has been set between \u20b996 and \u20b9100 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 1,200 shares worth \u20b91,21,200. Moreover, NIIs are required to bid for a minimum of 2 lots (2,400 shares) worth \u20b92,42,400.<br><\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Who is the registrar of <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong>?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Kfin Technologies Limited is the registrar of <strong>Accretion Pharmaceuticals IPO<\/strong><strong>,<\/strong> awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Accretion Pharmaceuticals IPO allotment and refund, you can contact Kfin Techologies Limited at <a href=\"mailto:reachus@kfintech.com\">reachus@kfintech.com<\/a> or 04067162222, 04079611000.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the <\/em><em>Accretion Pharmaceuticals IPO<\/em><em>, download the <\/em><em>Accretion Pharmaceuticals IPO<\/em><em> RHP and <\/em><em>Accretion Pharmaceuticals IPO<\/em><em> DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/stocks-to-watch-today-14th-may-2025\">Stocks to Watch Today: 14th May 2025 | SBI Life, HDFC Life, GAIL, EPL, Taneja, &amp; More!<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/accretion-pharmaceuticals-ipo\">Accretion Pharmaceuticals IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/rvnl-share-surges-8-percent\">RVNL Share surges 8% on Order Win Despite Weak Technics: Check Key Highlights Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/integrity-infrabuild-developers-ipo-gmp\">Integrity Infrabuild Developers IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/sensex-trades-down-nifty50-plunged\">Sensex Trades 800 Points Down; Nifty50 Plunged 0.75%: Escalation of Western Border Tensions<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/stocks-to-watch-today-13th-may-2025\">Stocks to Watch Today: 13th May 2025 | SRF, KIMS, Raymond, HFCL, Cochin Shipyard, &amp; More!<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/trent-ltd-share-surges-despite-dull-q4-performance\">Trent Ltd. Share Surges 4.5% Despite Dull Q4 Performance<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Accretion Pharmaceuticals IPO GMP is \u20b98 as of 14th May 2025. The IPO opens for bidding today, 14th May 2025, and will close on 16th May 2025. It is a bookbuilding IPO consisting of a fresh issue of 29.46 lakh shares worth \u20b929.75 crores. The issue will be listed on NSE and SME on its<\/p>\n","protected":false},"author":23,"featured_media":40596,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-40595","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"_edit_lock":["1747200549:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:69:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/accretion-image-2.jpg\";a:2:{s:2:\"id\";i:40597;s:11:\"source_type\";s:13:\"media-library\";}s:78:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/accretion-image-2-1024x536.jpg\";a:2:{s:2:\"id\";i:40597;s:11:\"source_type\";s:13:\"media-library\";}s:101:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2.jpg\";a:2:{s:2:\"id\";i:40597;s:11:\"source_type\";s:13:\"media-library\";}s:110:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105421\/accretion-image-2-1024x536.jpg\";a:2:{s:2:\"id\";i:40597;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_seo_score":["72"],"rank_math_focus_keyword":["Accretion Pharmaceuticals IPO GMP"],"_thumbnail_id":["40596"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_title":["Accretion Pharmaceuticals IPO GMP Day 1 | Check IPO Details"],"rank_math_description":["Check the Accretion Pharmaceuticals IPO GMP price. Discover the IPO Price, Date, Subscription Status, Grey Market Premium GMP, Allotment, Listing Date, and Review!"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_primary_category":["842"],"rank_math_analytic_object_id":["1948"],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/accretion-pharmaceuticals-ipo-gmp"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/14105338\/accretion-image-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=40595"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40595\/revisions"}],"predecessor-version":[{"id":40598,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40595\/revisions\/40598"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/40596"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=40595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=40595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=40595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}